ANG-2 and TIE2 dual binding antibody, called ABTAA, exerts ANG-2-neutralizing and TIE2-activation properties that enhance vascular normalization in gliomas, Lewis lung carcinoma, and MMTV-PyMT breast cancer models (Park et al. 2016). This evidence concerns the gene TEK and breast cancer.